VanderbiltHealth.com: For Patients and Visitors
Vanderbilt University Medical Center: For Employees, Researchers, and Students

CONTACT THE CDTR

Center for Diabetes Translation Research
1215 21st Avenue South
Suite 6000-North Tower
Nashville, Tennessee 37232

Pilot & Feasibility

Funding Opportunity for Diabetes Translation Research

The Vanderbilt Center for Diabetes Translation Research (CDTR) has funds available (up to $30,000 per year for two years) to support pilot studies in translational research in the area of diabetes or obesity beginning September 1, 2014. The aim of the Vanderbilt Center for Diabetes Translation Research is to improve prevention and treatment of diabetes and/or obesity by promoting research that supports implementation, dissemination, and sustained use of effective interventions or approaches that improve the health of individuals with diabetes of obesity. The center seeks to support type II translation research. The NIDDK defines type II translational research (e.g. bedside to practice and the community) as testing innovative adaptations of evidence based approaches to prevent and treat diabetes and/or obesity that can be disseminated and sustained in clinical health care practice and other settings outside of the traditional academic research setting.

 For the purpose of this FOA, type II translation is defined as research focused on translating interventions/approaches that have clearly demonstrated efficacy into real world health care settings, communities, and populations at risk. Type II translational research is distinct from type I translational research. Type I translational research (bench to bedside) builds on basic science findings and focuses on early phase research to “translate” these findings into potential interventions or therapeutics that might ultimately be tested in clinical trials. While type I translational research is a critically important piece of the research continuum, it is not the focus of this announcement. Type II translational research supported by the CDTR might include effectiveness, dissemination, implementation, and research. The target of this type of the research can be varied to include individuals, families, healthcare practitioners or systems, communities, and/or policy makers.

These funds are intended for:

  1. New investigators with an interest in a career in diabetes or obesity research,
  2. Investigators from other fields willing to bring their research expertise to diabetes- or obesity-relevant research,
  3. Investigators currently in the diabetes area whose proposed research constitutes a new direction, or for clinical and translational researchers who propose a joint research project.

The CDTR continues a collaborative relationship with the Vanderbilt Diabetes Research and Training Center in the pursuit of translational research.  This funding opportunity is, however, distinct from those of the Vanderbilt Diabetes Research and Training Center.
 
Application deadline is 11:59pm (CDT), March 10, 2014.

Submission Guidelines

The application should be submitted on the NIH form PHS 398, which can be obtained from the website: http://grants.nih.gov/grants/funding/phs398/phs398.html.

The pages we require are:
face page
abstract
key personnel
biosketch(es)
resources
research description (FIVE PAGE LIMIT)
literature cited pages
Letter(s) of collaboration
Letter from departmental chair if Research Track Faculty

The application must be assembled into a single PDF document that contains all grant materials including letters of collaboration. Research track faculty MUST include a letter from his/her departmental chair describing how this award will serve in developing an independent research program and external research funding; this letter should also be included in the PDF.

Submit the following by the deadline: 11:59pm (CDT), March 10, 2014.
1. The PDF should be submitted electronically to dc.brown@vanderbilt.edu. Also include the names, institutions and email addresses of TWO potential INTERNAL and TWO potential EXTERNAL reviewers. These individuals cannot be collaborators or members of your department.
2. SIX hard copies (stapled) should be delivered to Ms. Deborah Brown in room 802 Light Hall. Note that it is NOT necessary for the application to go through the Office of Sponsored Programs (formerly Office of Grants and Contracts Management) prior to submission.

 QUESTIONS: Persons considering submitting a proposal and not certain of eligibility or persons with questions about Pilot and Feasibility grants should contact Dr. Tom Elasy (615-936-7772 or tom.elasy@vanderbilt.edu). For questions about the grant submission process, please contact Ms. Deborah Brown (615-322-7990 or dc.brown@vanderbilt.edu).

 REVIEW CRITERIA: Proposed P&F studies should present a testable hypothesis and clearly delineate the question being asked, detail procedures to be followed, and discuss how the data will be analyzed and lead to future studies. Grants receive both internal and external review. Emphasis is placed on how the research might lead to new research ideas or research funding. For junior investigators, additional considerations include how this award will impact your career and the potential of the applicant to compete for independent research funding in the future. Research track faculty MUST include a letter from his/her departmental chair describing how this award will serve in developing an independent research program and external research funding.

Funded investigators must prepare a yearly progress report and may be required to participate in the DRTC Seminar Series and Diabetes Day Program.

 

Copyright © 2014 by Vanderbilt University Medical Center    |    1211 Medical Center Drive    |    Nashville, TN 37232    |    (615) 322-5000
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
This page was last updated January 23, 2014 and is maintained by Terri Ray